Riskpilot← Back to searchSign inGet full accessHagalundkliniken AB
ABActiveOrg 5590671680Lavendelgatan 2Beauty care and other beauty treatment activities · NACE 9622Est. 20161-4 employees
Revenue 2025
SEK 124K
+26% vs 2024
EBITDA margin
-40.0%
+44% vs 2024
Equity ratio
25.1%
Financial strength
Net profit 2025
SEK -50K
+44% vs 2024
| Revenue | SEK 124K | +26% |
| EBITDA | SEK -50K | +44% |
| Net profit | SEK -50K | +44% |
| Total assets | SEK 65K | -38% |
| Equity | SEK 16K | -75% |
| Employees | — | — |
Legal name
Hagalundkliniken AB
Org number
5590671680
Legal form
Aktiebolag
NACE code
9622 · Beauty care and other beauty treatment activities
Founded
21 juni 2016
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva hudvårdssalong, massage, ansiktsbehandling, avancerad hudvård såsom kemisk peeling, microneedling, injektioner av fillers och botox och fransförlängning samt webbshop av hudvårdsprodukter.
Address
Lavendelgatan 2
Email
hagalundkliniken@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 50 | 60 | 61 | 99 | 124 |
| Staff expenses | — | −11 | −14 | −57 | −11 |
| EBITDA | −35 | −1 | −4 | −89 | −50 |
| Depreciation & amort. | −10 | −10 | −4 | — | — |
| EBIT | −45 | −12 | −8 | −89 | −50 |
| Net financials | — | −1 | 0 | 0 | 0 |
| Profit before tax | −45 | −12 | −8 | −89 | −50 |
| Tax | −0 | — | — | — | — |
| Net profit | −45 | −12 | −8 | −89 | −50 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 57 | 50 | 83 | 106 | 65 |
| Equity | 5 | −8 | −15 | 66 | 16 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 52 | 57 | 98 | 40 | 49 |
| Total debt | 52 | 57 | 98 | 40 | 49 |
EBITDA margin
-40.0%
This company
15.8%
Market median
-353% vs market
20212025
Equity ratio
25.1%
This company
38.2%
Market median
-34% vs market
20212025
Return on equity
-302.0%
This company
18.4%
Market median
-1741% vs market
20212025
Net profit margin
-39.9%
This company
8.1%
Market median
-593% vs market
20212025
Asset turnover
1.90×
This company
1.12×
Market median
+70% vs market
20212025
Debt / equity
2.99×
This company
0.62×
Market median
-382% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2020 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Hagalundkliniken AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carl Henrik Eriksson Kindberg | Deputy Board Member | 0 companies |
| Gun Ann-Sofie Eriksson Kindberg | Board of Directors | 0 companies |
| Amanda Evelina Ljung Andersson | Deputy Board Member | 0 companies |